22 November 2017
News and Views
Links and Services
Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy, reports this month's issue of the American Journal of Gastroenterology.
Cirrhotics with minimal hepatic encephalopathy have a poor health-related quality of life.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors